Nampt/PBEF/visfatin upregulation in colorectal tumors, mirrored in normal tissue and whole blood of colorectal cancer patients, is associated with metastasis, hypoxia, IL1 β, and anemia

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Neubauer, Katarzyna ^a   Bednarz Misa, Iwona ^a   Diakowska, Dorota ^a   Kapturkiewicz, Bartosz ^b   Gamian, Andrzej ^a,c   Krzystek Korpacka, Malgorzata ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Wroclaw   (Poland)

^c WROCLAW RESEARCH CENTRE EIT   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLATELET DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; CYTOKINE; IL1B PROTEIN, HUMAN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; TUMOR PROTEIN;

ADENOCARCINOMA CELL LINE; ADULT; AGED; ANEMIA; ARTICLE; BLOOD; CANCER GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; ERYTHROCYTE; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; LEUKOCYTE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR LOCALIZATION; UPREGULATION; VERY ELDERLY; CLINICAL TRIAL; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; METASTASIS; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; UP-REGULATION;

EID: 84930664814     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/523930     Document Type: Article

References (32)

1. S.-I. Imai, "Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases", Current Pharmaceutical Design, vol. 15, no. 1, pp. 20-28, 2009.
2. T.-Q. Bi and X.-M. Che, "Nampt/PBEF/visfatin and cancer", Cancer Biology & Therapy, vol. 10, no. 2, pp. 119-125, 2010.
3. U. Galli, C. Travelli, A. Massarotti et al., "Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors", Journal of Medicinal Chemistry, vol. 56, no. 16, pp. 6279-6296, 2013.
4. M. Pittelli, L. Cavone, A. Lapucci et al., "Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes", Immunology and Cell Biology, vol. 92, no. 2, pp. 191-199, 2014.
5. S. E. Hufton, P. T. Moerkerk, R. Brandwijk, A. P. De Brüíne, J.-W. Arends, and H. R. Hoogenboom, "A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization", FEBS Letters, vol. 463, no. 1-2, pp. 77-82, 1999.
6. J. R. Van Beijnum, P. T. M. Moerkerk, A. J. Gerbers et al., "Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer", International Journal of Cancer, vol. 101, no. 2, pp. 118-127, 2002.
7. T. E. Nakajima, Y. Yamada, T. Hamano et al., "Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer", Cancer Science, vol. 101, no. 5, pp. 1286-1291, 2010.
8. M. S. Fazeli, H. Dashti, S. Akbarzadeh et al., "Circulating levels of novel adipocytokines in patients with colorectal cancer", Cytokine, vol. 62, no. 1, pp. 81-85, 2013.
9. M. Chen, Y. Wang, Y. Li et al., "Association of plasma visfatin with risk of colorectal cancer: an observational study of Chinese patients", Asia-Pacific Journal of Clinical Oncology, 2013.
10. T. Luk, Z. Malam, and J. C. Marshall, "Pre-B cell colonyenhancing factor (PBEF)/visfatin: a novel mediator of innate immunity", Journal of Leukocyte Biology, vol. 83, no. 4, pp. 804-816, 2008.
11. M. Krzystek-Korpacka, D. Diakowska, J. Bania, and A. Gamian, "Expression stability of common housekeeping genes is differently affected by bowel inflammation and cancer: implications for finding suitable normalizers for inflammatory bowel disease studies", Inflammatory Bowel Diseases, vol. 20, no. 7, pp. 1147-1156, 2014.
12. M. Krzystek-Korpacka, D. Diakowska, B. Kapturkiewicz, M. Bebenek, and A. Gamian, "Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance", Cancer Letters, vol. 337, no. 1, pp. 107-114, 2013.
13. J. Vandesompele, K. De Preter, F. Pattyn et al., "Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes", Genome Biology, vol. 3, no. 7, Article ID RESEARCH0034, 2002.
14. S. T. Patel, T. Mistry, J. E. P. Brown et al., "A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis", Peptides, vol. 31, no. 1, pp. 51-57, 2010.
15. L. Hawthorn, L. Lan, and W. Mojica, "Evidence for field effect cancerization in colorectal cancer", Genomics, vol. 103, no. 2-3, pp. 211-221, 2014.
16. C. C. S. Chini, A. M. G. Guerrico, V. Nin et al., "Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors", Clinical Cancer Research, vol. 20, no. 1, pp. 120-130, 2014.
17. T.-Q. Bi, X.-M. Che, X.-H. Liao et al., "Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil", Oncology Reports, vol. 26, no. 5, pp. 1251-1257, 2011.
18. D. Cerna, H. Li, S. Flaherty, N. Takebe, C. N. Coleman, and S. S. Yoo, "Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1) - dependent manner", The Journal of Biological Chemistry, vol. 287, no. 26, pp. 22408-22417, 2012.
19. C. Zhang, J. Tong, and G. Huang, "Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells", PLoS ONE, vol. 8, no. 7, Article ID e69963, 2013.
20. S. H. Jia, Y. Li, J. Parodo et al., "Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis", Journal of Clinical Investigation, vol. 113, no. 9, pp. 1318-1327, 2004.
21. Y. Li, Y. Zhang, B. Dorweiler et al., "Extracellular Nampt promotes macrophages survival via a non-enzymatic interleukin-6/STAT3 signaling mechanism", The Journal of Biological Chemistry, vol. 283, pp. 34833-34843, 2008.
22. A. Rongvaux, M. Galli, S. Denanglaire et al., "Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress", Journal of Immunology, vol. 181, no. 7, pp. 4685-4695, 2008.
23. K. Neubauer and M. Krzystek-Korpacka, "Visfatin/PBEF/Nampt and other adipocytokines in inflammatory bowel disease", Advances in Clinical and Experimental Medicine, vol. 19, no. 3, pp. 399-404, 2010.
24. A. R. Moschen, A. Kaser, B. Enrich et al., "Visfatin, an adipocytokine with proinflammatory and immunomodulating] properties", The Journal of Immunology, vol. 178, no. 3, pp. 1748-1758, 2007.
25. R. Adya, B. K. Tan, A. Punn, J. Chen, and H. S. Randeva, "Visfatin induces human endothelial VEGF and MMP-2/9 production viaMAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis", Cardiovascular Research, vol. 78, no. 2, pp. 356-365, 2008.
26. Y.-H. Bae, M.-K. Bae, S.-R. Kim, J. H. Lee, H.-J. Wee, and S.-K. Bae, "Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis", Biochemical and Biophysical Research Communications, vol. 379, no. 2, pp. 206-211, 2009.
27. S.-K. Bae, S.-R. Kim, J. G. Kim et al., "Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1", FEBS Letters, vol. 580, no. 17, pp. 4105-4113, 2006.
28. K. Segawa, A. Fukuhara, N. Hosogai et al., "Visfatin in adipocytes is upregulated by hypoxia through HIF1α-dependent mechanism", Biochemical and Biophysical Research Communications, vol. 349, no. 3, pp. 875-882, 2006.
29. K. Holen, L. B. Saltz, E. Hollywood, K. Burk, and A.-R. Hanauske, "The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor", Investigational New Drugs, vol. 26, no. 1, pp. 45-51, 2008.
30. S. Pirkmajer and A. V. Chibalin, "Serum starvation: caveat emptor", The American Journal of Physiology-Cell Physiology, vol. 301, no. 2, pp. C272-C279, 2011.
31. P. Minoo, I. Zlobec, M. Peterson, L. Terracciano, and A. Lugli, "Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles", International Journal of Oncology, vol. 37, no. 3, pp. 707-718, 2010.
32. M. Krzystek-Korpacka, D. Diakowska, K. Grabowski, and A. Gamian, "Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study", International Journal of Colorectal Disease, vol. 27, no. 10, pp. 1319-1324, 2012.